BOS 50 Pfizer Pill - orange & white capsule/oblong
Generic Name: bosutinib
Pill with imprint BOS 50 Pfizer is Orange & White, Capsule/Oblong and has been identified as Bosulif 50 mg. It is supplied by Pfizer Inc.
Bosulif is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BOS 50 Pfizer
Bosulif
- Generic Name
- bosutinib
- Imprint
- BOS 50 Pfizer
- Strength
- 50 mg
- Color
- Orange & White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0504
More about Bosulif (bosutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
